Cancer Survivors Show Positive Views on Cannabis but Fear Opioid Stigma, Small Study Finds
This study explores cannabis stigma cancer survivors experience and its influence on their symptom management choices. Many patients reported positive views on cannabis but feared opioid stigma more. Some cancer survivors also concealed cannabis use from…
Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives.
This study aims to assess for indications of stigma and attitudes toward cannabis among cancer survivors (CS) who use or consider the use of cannabis. This s...
Demographics, Methods, and Perceived Benefits of Cannabis Use in Cancer Patients
This study examines cannabis use among cancer patients, focusing on demographics, methods, and perceived benefits. It highlights key factors influencing use and patient experiences. Understanding cannabis use among cancer patients can inform clinical…
Amrit Baral: Cannabis and Psychedelic Use Among Older U.S. Cancer Survivors
Psychedelic use older cancer survivors is an emerging area of clinical interest. This article provides estimates that inform screening and safety considerations. Understanding these patterns helps optimize symptom management in older cancer survivors.
Surveyed Cancer Patients Worry About Cannabis Access Barriers
Cancer patients face significant cannabis access barriers that influence their symptom management choices. Cost and legal concerns often outweigh clinical guidance, leading to suboptimal treatment. Addressing cannabis access barriers is crucial for…
‘Medical cannabis has cured my severe social anxiety and PTSD’ says Milton Keynes artist
Patient testimonials cannabis anxiety PTSD highlight individual experiences with symptom relief. Cannabis may offer meaningful symptom management but is not a cure. Clinical evidence supports its role as adjunctive therapy for anxiety and PTSD.
World’s largest cart and battery!
When your patient asks if there’s a higher-capacity option, remind them that bigger hardware doesn’t necessarily mean better pharmacokinetics. The real question is whether they’re treating symptoms or just collecting peripherals. Via…
The Hemp Industry Gears Up to Fight for Its Continued Existence – Roundtable
The hemp-derived cannabinoids regulation is a critical issue facing the hemp industry today. Regulatory uncertainty threatens patient access to many hemp products used for symptom management. Clinicians must stay informed to guide patients effectively…
Judge Temporarily Blocks Texas Smokeable Hemp Ban
The temporary block on Texas hemp smokeable products ban creates uncertainty for patients relying on these products. This ruling affects legal access and regulatory clarity in Texas. Clinicians must stay informed about evolving hemp product regulations.
Salus at Drexel University Hosts Continuing Education on Medical Cannabis
The continuing education medical cannabis event at Drexel University aims to improve clinician understanding of cannabis pharmacology. This program focuses on the endocannabinoid system and its therapeutic relevance. Physicians will gain essential…